Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 02, 2007. The report details a specific corporate action regarding the repurchase of the company's own shares in accordance with shareholder authority granted at the Annual General Meeting on May 17, 2006.
Key Financial Metrics
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed is the share repurchase price of 1,393.6635 pence per share.
Material Changes
On April 2, 2007, the Company purchased 600,000 Ordinary shares of 25 pence each. Following this transaction, the total number of shares held in Treasury increased to 281,982,678. The number of shares in issue (excluding Treasury shares) stands at 5,728,483,566, which represents the total voting rights in the Company.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It explicitly states that the announcement does not constitute an offer or solicitation to purchase securities and conforms to the Transparency Directive's transitional provision 6.
Key Facts for Investor Verification
- Share repurchase volume: 600,000 shares.
- Repurchase date: April 2, 2007.
- Price per share: 1,393.6635 pence.
- Total Treasury shares post-transaction: 281,982,678.
- Total shares in issue (voting rights): 5,728,483,566.